Banner image placeholder
Banner image
B
Christopher Barrett
MD

Curriculum vitae


Surgery Department

UNMC



Influence of Tranexamic Acid on Inflammatory Signaling in Trauma


Journal article


Christopher D. Barrett, Y. Kong, M. Yaffe
Seminars in Thrombosis and Hemostasis, 2020

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Barrett, C. D., Kong, Y., & Yaffe, M. (2020). Influence of Tranexamic Acid on Inflammatory Signaling in Trauma. Seminars in Thrombosis and Hemostasis.


Chicago/Turabian   Click to copy
Barrett, Christopher D., Y. Kong, and M. Yaffe. “Influence of Tranexamic Acid on Inflammatory Signaling in Trauma.” Seminars in Thrombosis and Hemostasis (2020).


MLA   Click to copy
Barrett, Christopher D., et al. “Influence of Tranexamic Acid on Inflammatory Signaling in Trauma.” Seminars in Thrombosis and Hemostasis, 2020.


BibTeX   Click to copy

@article{christopher2020a,
  title = {Influence of Tranexamic Acid on Inflammatory Signaling in Trauma},
  year = {2020},
  journal = {Seminars in Thrombosis and Hemostasis},
  author = {Barrett, Christopher D. and Kong, Y. and Yaffe, M.}
}

Abstract

Abstract Plasmin generation in trauma patients has wide-ranging effects, from breakdown of clots to remodeling the extracellular matrix. An evolving recognition of plasmin as a critical effector molecule in various inflammatory signals and pathways has rendered the study of plasmin(ogen) and its regulation by upstream activators and downstream targets and inhibitors key to understanding the inflammatory responses to trauma. Tranexamic acid, a widely available lysine analogue medication on the World Health Organization's list of essential medicines, has rapidly become one of the most commonly implemented adjunct treatments for bleeding after traumatic injury in clinical practice. In this article, we review the effects, both anti- and proinflammatory, of tranexamic acid, with a focus on the injured trauma patient.


Share

Translate to